Economic Barometer

Part of NCDP’s National Diabetes Triple Barometer, this measures the direct and indirect economic costs of diabetes and pre-diabetes in the U.S. The research, conducted by The Lewin Group, found that the U.S. spent $218 billion in 2007 on diabetes, including costs for undiagnosed diabetes, pre-diabetes and gestational diabetes, which had not been considered in previous studies. This barometer also examines the cost of type 1 diabetes relative to the cost for type 2.

Economic Barometer News & Press

• "The Economic Burden of Diabetes." (Health Affairs Article) – 01/14/2010
• "Using Clinical Information to Project Federal Health Care Spending." (Health Affairs Article) – 09/2009
• "Pre-Diabetes Costs Nation $25 Billion Annually in Extra Medical Care, New Data Show" (Press Release) -- 06/24/2009
• "The Economics of Diabetes in the United States" Complete research published in Population Health Management. Research was conducted by the Lewin Group and commissioned by the National Changing Diabetes Program
  • "Medical Cost Associated with Prediabetes" Population Health Management (Journal Article) -- 06/17/2009
  • "Cost of Gestational Diabetes Mellitus in the United States in 2007" Population Health Management (Journal Article) -- 06/17/2009
  • "The Economic Costs of Undiagnosed Diabetes" Population Health Management (Journal Article) -- 04/10/2009
  • "Distinguishing the Economic Costs Associated with Type 1 and Type 2 Diabetes" Population Health Management (Journal Article) -- 04/10/2009
• "Americans Who Don't Know They Have Diabetes Incur $18 Billion in Health Expenses Each Year" (Press Release) -- 05/20/2009
• Conquering the Diabetes Epidemic: Costs and Opportunities (Article) -- 02/25/2009
• Innovation in Health Care: The Economics of Diabetes (Research Abstracts) -- 11/18/2008
• Study Finds Cost of Diabetes in the United States Exceeds $218 Billion (Press Release) -- 11/18/2008
• Study Puts a Total on Diabetes Cost: $218 Billion (Article) -- 11/18/2008